Site Search

BISMARCK, N.D. –– North Dakota legislators have strong momentum against cancer heading into the second half of the session as bills on prior authorization reform, supplemental breast cancer detection screenings and co-pay accumulator adjustments are ... Prior authorization reform: For the more than 4,500 North Dakotans who will be diagnosed with cancer in 2025, medical prior authorization can delay treatment, increase stress and have a negative impact on care. Senate Bill 2280 would establish standards and transparency to prior ... breast diagnostic mammograms (x-rays), breast ultrasounds, and breast magnetic resonance imaging (MRI) scans be covered by insurers at no-cost-share when deemed medically necessary by their physician. It would allow North Dakotans to complete the full continuum of breast cancer ...

... breast cancer. Research shows that access to quality and affordable health care coverage is key in the ability to fight cancer. Cancer is one of the leading causes of disease and death in the United States. An analysis by the American Cancer Society Cancer Action Network (ACS CAN) shows that cancer patients pay nearly $4 billion in out-of-pocket costs each year and the disease cost the country nearly $88 billion every year in health care spending. On Friday, October 26, a group of patient advocates, health care experts, ...

A new report by the American Cancer Society Cancer Action Network (ACS CAN) found that over 70% of commercially-insured patients encountered out-of-pocket expenses for follow-up breast cancer diagnostic tests in 2023. ... MRI, ultrasound or biopsy, are medically recommended next steps to determine if an individual may or may not have cancer; however, barriers like cost can keep people from getting them. While screening mammograms are free to most insured women starting at age 40, follow-up testing after a ...

... afford breast cancer screenings. HB300 would make sure any state-regulated health insurance plan covers follow-up diagnostic imaging without any cost-sharing, including a deductible. A recent report  by the American Cancer Society Cancer Action Network (ACS CAN) found that over 70% of commercially-insured patients encountered out-of-pocket expenses for follow-up breast cancer diagnostic tests in 2023. These follow-up tests, ...